BlackRock Inc. Buys Shares of 1,278,871 AirSculpt Technologies, Inc. $AIRS

Key Points

• BlackRock acquired 1,278,871 shares of AirSculpt Technologies during the second quarter, worth approximately $5.76 million and representing about 1.81% of the company. Institutional investors collectively own 91.54% of AirSculpt’s stock.
• Analyst sentiment remains cautious: AirSculpt has an average “Reduce” rating, with one Hold and one Sell rating, and a consensus price target of $4.50.
• AirSculpt reported quarterly EPS of $0.01, below the $0.02 consensus estimate, while revenue of $42.9 million also missed expectations of $44.14 million. Shares opened at $2.80, with the stock trading well below its 52-week high of $12.00.

BlackRock Inc. bought a new stake in AirSculpt Technologies, Inc. (NASDAQ:AIRS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,278,871 shares of the company's stock, valued at approximately $5,755,000. BlackRock Inc. owned about 1.81% of AirSculpt Technologies at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in AirSculpt Technologies by 259.6% in the first quarter. Royal Bank of Canada now owns 9,879 shares of the company's stock valued at $28,000 after buying an additional 7,132 shares during the period. Virtu Financial LLC acquired a new stake in AirSculpt Technologies during the 4th quarter worth $30,000. Millennium Management LLC acquired a new stake in AirSculpt Technologies during the 4th quarter worth $33,000. Aigen Investment Management LP acquired a new stake in AirSculpt Technologies during the 4th quarter worth $36,000. Finally, Wells Fargo & Company MN raised its position in shares of AirSculpt Technologies by 49.9% during the 4th quarter. Wells Fargo & Company MN now owns 19,275 shares of the company's stock valued at $38,000 after acquiring an additional 6,420 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company's stock.

Analyst Ratings Changes

AIRS has been the subject of a number of analyst reports. Leerink Partners set a $4.50 price objective on AirSculpt Technologies in a research note on Thursday, May 14th. Weiss Ratings raised AirSculpt Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, July 1st. Finally, Wall Street Zen cut AirSculpt Technologies from a "buy" rating to a "hold" rating in a report on Saturday, August 15th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Reduce" and a consensus price target of $4.50.

AirSculpt Technologies Trading Up 10.2%

Shares of NASDAQ AIRS opened at $2.80 on Friday. The company's fifty day moving average is $3.86 and its 200-day moving average is $3.59. The stock has a market cap of $201.87 million, a price-to-earnings ratio of -15.55 and a beta of 2.25. AirSculpt Technologies, Inc. has a twelve month low of $1.51 and a twelve month high of $12.00. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The firm had revenue of $42.90 million during the quarter, compared to analyst estimates of $44.14 million. AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc NASDAQ: AIRS is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source